コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 40s who developed DIHS after treatment with carbamazepine.
2 pharmacological rescue by glibenclamide and carbamazepine.
3 er by the prototypical Na(+) channel blocker carbamazepine.
4 he antiepileptic drug topiramate, but not by carbamazepine.
5 accumulated to a greater degree in bile than carbamazepine.
6 alproate and for lower verbal abilities with carbamazepine.
7 s alleviated by the sodium channel inhibitor carbamazepine.
8 with epilepsy or seizure when compared with carbamazepine.
9 nts compared with topiramate and secondarily carbamazepine.
10 agents, and possibly the antiepileptic agent carbamazepine.
11 non-inferiority of lamotrigine compared with carbamazepine.
12 cochaperones glibenclamide, repaglinide, and carbamazepine.
13 rotein-induced EAE treated with phenytoin or carbamazepine.
14 c treatments such as lithium, valproate, and carbamazepine.
15 s the best candidate enzyme for metabolizing carbamazepine.
16 taking placebo to 3015 minutes while taking carbamazepine.
17 taking placebo to 45.3 minutes while taking carbamazepine.
18 ally relevant thermal stimuli was reduced by carbamazepine.
19 intenance period to 136 minutes while taking carbamazepine.
20 enance period and 32 awakenings while taking carbamazepine.
21 ndetectable or significantly lower levels of carbamazepine.
22 d with pain during treatment with placebo or carbamazepine.
23 87, 0.85-0.90), and treatment (gabapentin vs carbamazepine, 0.71, 0.59-0.86; topiramate vs carbamazep
28 ure toxicity of four putative OBPs, that is, carbamazepine 10,11-epoxide, 10,11-Dihydrocarbamazepine,
29 ere validated using metabolites (10,11-epoxy carbamazepine, 10,11-dihydroxy carbamazepine, and acridi
30 uding 10,11-dihydro-10-hydroxycarbamazepine, carbamazepine-10,11-epoxide, acridone-N-carbaldehyde, 4-
32 o valproate (mean 97, 95% CI 94-101) than to carbamazepine (105, 102-108; p=0.0015), lamotrigine (108
33 ed by oxcarbazepine (46%), duloxetine (30%), carbamazepine (26%), topiramate (25%), pregabalin and ga
35 e paralleled by pharmacological coupling, as carbamazepine (30 muM) depolarizes S214T activation, as
36 ghted average concentration: 250-4800 ng/L), carbamazepine (33-910 ng/L), diclofenac (78-1000 ng/L),
37 thoxazole (2-33 days), naproxen (6-19 days), carbamazepine (355-1,624 days), and ciprofloxacin were n
38 e taking placebo to 9.1 minutes while taking carbamazepine (400 mg then 200 mg/day), and a reduction
39 taking placebo to 231.9 minutes while taking carbamazepine (400 mg/day), and a reduction in total TIP
40 oxen, 82 +/- 3% for ibuprofen, 66 +/- 2% for carbamazepine, 57 +/- 15% for tylosin, and 88 +/- 1% for
41 95% CI 5.5% to 8.3%) compared with 2.6% with carbamazepine (95% CI 1.9% to 3.5%) and 2.3% with lamotr
45 ates suggest a non-significant advantage for carbamazepine against lamotrigine (0.91 [0.77-1.09]), to
51 e further evaluate the possibility to detect carbamazepine, an antiepileptic massively prescribed and
52 mazepine was only transformed to 10,11-epoxy carbamazepine and 10,11-dihydroxy carbamazepine as a dea
53 ard and feedback inhibition is unaffected by carbamazepine and additional commonly used Na(+) channel
54 by the use-dependent sodium channel blocker carbamazepine and by a blocker of reverse Na-Ca exchange
57 ies showed complete elimination of (14)C for carbamazepine and fluoxetine treatments and partial elim
59 vidence that despite structural differences, carbamazepine and glibenclamide compete for binding to K
60 HLA) associations: abacavir and HLA-B*57:01, carbamazepine and HLA-B*15:02, allo-purinol and HLA-B*58
62 laimed wastewater-irrigated produce excreted carbamazepine and its metabolites in their urine, while
63 public alphabetaTCR has binding affinity for carbamazepine and its structural analogs, thereby mediat
67 endent rapamycin as well as mTOR-independent carbamazepine and minoxidil, markedly attenuated cyst fo
68 uticals acetaminophen, sulfamethoxazole, and carbamazepine and on the pharmaceutical intermediate 5-m
72 s treatment with the sodium channel blockers carbamazepine and oxcarbazepine, which although effectiv
74 treatments with antiepileptic drugs, such as carbamazepine and phenytoin, which are sodium channel bl
75 f sodium channels, in contrast to drugs like carbamazepine and phenytoin, which bind tightly to fast-
76 Triazolam, oral midazolam, St. John's Wort, carbamazepine and pimozide, are contraindicated with DAA
79 mug L(-1)), and several compounds, including carbamazepine and sulfamethoxazole, were detected throug
80 One of the pharmacological treatments is Carbamazepine and the most prevalent surgical treatments
86 chemicals (boron), pharmaceutical compounds (carbamazepine), and steroidal estrogens (estrone, 17-bet
87 xposed to phenytoin, 98 for those exposed to carbamazepine, and 92 for those exposed to valproate.
88 (10,11-epoxy carbamazepine, 10,11-dihydroxy carbamazepine, and acridine) as primary substrates and f
89 nt mood stabilizers, e.g., valproic acid and carbamazepine, and atypical antipsychotic drugs (APDs),
91 Lamotrigine, 10,11,-dihydro-10,11,-dihydroxy-carbamazepine, and carbamazepine were the most persisten
92 ine, olanzapine, ziprasidone, valproic acid, carbamazepine, and citalopram were associated with highe
93 ions of triclosan, triclocarban, miconazole, carbamazepine, and diphenhydramine in plant tissues that
94 range (0.5 to 200 mug/mL for sulfamethazine, carbamazepine, and flavone), and low noise levels (at 30
96 he tricyclic anticonvulsant drugs phenytoin, carbamazepine, and lamotrigine block neuronal voltage-ga
97 orketamine, O-desmethyltramadol, diclofenac, carbamazepine, and methoxetamine were not substantially
99 Finally, rapamycin as well as spermidine, carbamazepine, and tamoxifen could also rescue the motor
100 hree other autophagy activators (spermidine, carbamazepine, and tamoxifen) in a FTLD-U mouse model wi
101 odegradation rate constants of atorvastatin, carbamazepine, and venlafaxine, which react primarily wi
102 lsant mood stabilizers (AMS), valproic acid, carbamazepine, and zonisamide, but not lithium, also pre
104 ely prescribed anticonvulsants phenytoin and carbamazepine are potent inducers of cytochrome P450 enz
107 sample volume were evaluated for five drugs: carbamazepine, atenolol, sulfamethazine, diazepam, and a
108 odynamic analysis, and functional profiling, carbamazepine attenuated pain in patients with IEM due t
110 1.7 angstrom resolution, which reveals that carbamazepine binds at a novel pocket on the FZD8 CRD.
111 onic or uncharged trimethoprim and uncharged carbamazepine, but did not affect sequestration of fast-
112 Advanced oxidation can efficiently degrade carbamazepine, but the toxicity and persistence of the o
114 gate transport of phenytoin, lamotrigine and carbamazepine by using seven in-vitro transport models.
116 hether the products of advanced oxidation of carbamazepine can be biotransformed and ultimately miner
117 Cellular functional assays demonstrated that carbamazepine can suppress FZD8-mediated Wnt/beta-cateni
119 95% CI and p values for no difference) were: carbamazepine (CBZ) 0.43 (-0.19 to 1.05) p=0.17; lamotri
121 re we show that the autophagy-enhancing drug carbamazepine (CBZ) decreased the hepatic load of ATZ an
122 ed the impacts of chronic, low-concentration carbamazepine (CBZ) exposure on a suite of male reproduc
125 al sunlight photolysis of the pharmaceutical carbamazepine (CBZ) in the presence of dissolved organic
130 ental emission rates of alprazolam (APZ) and carbamazepine (CBZ) through domestic WWTPs (both sludge
131 rated TPs of the recalcitrant pharmaceutical carbamazepine (CBZ) were used for a target screening for
133 hlighting this difficulty, it is unclear why carbamazepine (CBZ), a frontline AED with a known molecu
135 nce immunoassay (SAFIA) for the detection of carbamazepine (CBZ), diclofenac (DCF), caffeine (CAF), a
137 (4)(2-), Fe(VI)) to oxidize pharmaceuticals (carbamazepine (CBZ), naproxen (NAP), trimethoprim (TMP),
138 ed the HLA-B *1502 genetic predisposition to carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJ
141 sing preliminary evidence include memantine, carbamazepine, citalopram, and prazosin, but none of the
142 ve metabolites of acetaminophen, diclofenac, carbamazepine, clozapine, p-cresol, 4-ethylphenol, and 3
143 esults show that the oxidation byproducts of carbamazepine containing a hydroxyl or carbonyl group ca
144 ically distinct compounds, glibenclamide and carbamazepine, correct biogenesis defects in ATP-sensiti
145 ths was 90% taking lacosamide and 91% taking carbamazepine-CR (absolute treatment-difference: -1.3%,
146 in the lacosamide group and 308 (70%) in the carbamazepine-CR group completed 6 months of treatment w
147 tients taking lacosamide and 43 (10%) taking carbamazepine-CR had serious treatment-emergent adverse
148 44 patients taking lacosamide and 442 taking carbamazepine-CR were included in the full analysis set
149 ay for lacosamide and 800 or 1200 mg/day for carbamazepine-CR) over 2 weeks with a 1-week stabilisati
151 doses of 100 mg/day lacosamide or 200 mg/day carbamazepine-CR, uptitration to the first target level
156 ), anti-anxiety diazepam (DZP), anti-seizure carbamazepine (CZP) drugs and their metabolites in groce
159 tigated the fate and uptake of (14)C-labeled carbamazepine, diclofenac, fluoxetine, and orlistat in s
160 rmaceuticals (acetazolamide, beclomethasone, carbamazepine, diclofenac, gemfibrozil, ibuprofen, ketop
161 r several other protein misfolding diseases, carbamazepine did not correct KATP channel trafficking d
165 osition was affected by flow conditions with carbamazepine dominating the base flow and caffeine domi
167 model to assess the removal of phenytoin and carbamazepine during HD with or without binding-competit
168 transformation products of the (14)C-labeled carbamazepine during UV/hydrogen peroxide advanced oxida
169 ons of widely monitored HHCB, triclosan, and carbamazepine explained 71-82% of the variability in the
171 armaceuticals found in reclaimed wastewater: carbamazepine, fluoxetine, amitriptyline, and lamotrigin
172 ile fish bioconcentrated both fluoxetine and carbamazepine from exposure water, fluoxetine accumulate
173 Patients were randomly assigned to receive carbamazepine, gabapentin, lamotrigine, oxcarbazepine, o
174 , and they were randomly assigned to receive carbamazepine, gabapentin, lamotrigine, oxcarbazepine, o
175 iprofloxacin, trimethoprim, propranolol, and carbamazepine (>80%) was achieved within 3 h of electrol
176 nnel inhibitors, including sulfonylureas and carbamazepine, have been shown to correct channel traffi
177 luding clopidogrel, pegylated-interferon and carbamazepine, have led to the identification of specifi
178 e, lamotrigine was significantly better than carbamazepine (hazard ratio [HR] 0.78 [95% CI 0.63-0.97]
181 interaction was observed for lamotrigine or carbamazepine in any of the seven validated in-vitro tra
182 harmacogenetic testing for HLA-B*1502 before carbamazepine in patients of certain Asian ethnicities a
183 e-Carlo based pharmacokinetic simulations of Carbamazepine in treatment of Trigeminal Neuralgia.
184 including human leukocyte antigen loci with carbamazepine-induced dermatologic outcome and MC4R with
185 ated the relationship between HLA-B*1502 and carbamazepine-induced SJS and TEN and that reported suff
186 lationship between the HLA-B*1502 allele and carbamazepine-induced SJS and TEN in Han-Chinese, Thai,
187 for the relationship between HLA-B*1502 and carbamazepine-induced SJS and TEN was 79.84 (95% CI, 28.
189 bacavir hypersensitivity and HLA-B*57:01 and carbamazepine-induced Stevens-Johnson syndrome and HLA-B
190 sgenic mice receiving oral administration of carbamazepine induces multi-organ injuries and symptoms
193 ntration 70 mg/L, using 2000 mg aspirin, (2) carbamazepine, initial concentration 35 mg/L, using 800
196 he widely used anticonvulsant pharmaceutical carbamazepine is recalcitrant in many environmental nich
198 achieving a 12-month remission (lamotrigine-carbamazepine) is 0 (-8 to 7) and 5 (-3 to 12), suggesti
199 ebo were significantly better tolerated than carbamazepine (lamotrigine, RR 5.24, 1.07-26.32; placebo
202 eatments, other than aripiprazole+valproate, carbamazepine, lamotrigine, and lamotrigine+valproate, o
203 ntiepileptics approved for bipolar disorder (carbamazepine, lamotrigine, and valproate) are associate
204 otrigine, aripiprazole+valproate, asenapine, carbamazepine, lamotrigine, lamotrigine+valproate, lithi
205 ed to maternal IQs among children exposed to carbamazepine, lamotrigine, or phenytoin but not among t
206 ified as either exposed to an antiepileptic (carbamazepine, lamotrigine, or valproate) or not exposed
207 fects exist across four commonly used drugs (carbamazepine, lamotrigine, phenytoin and valproate).
208 epilepsy on antiepileptic drug monotherapy (carbamazepine, lamotrigine, phenytoin, or valproate) bet
209 ho were taking a single antiepileptic agent (carbamazepine, lamotrigine, phenytoin, or valproate) in
210 men with epilepsy receiving monotherapy (ie, carbamazepine, lamotrigine, phenytoin, or valproate) wer
212 ion of the KATP channel opener diazoxide and carbamazepine led to enhanced mutant channel function wi
214 ption coefficients increased in the order of carbamazepine < diclofenac < fluoxetine < orlistat.
215 elimination of (14)C, increased in the order carbamazepine < diclofenac < fluoxetine and orlistat.
217 These findings suggest that phenytoin and carbamazepine may substantially increase the risk for ca
224 re exposed to valproate monotherapy, 1718 to carbamazepine monotherapy and 2198 to lamotrigine monoth
225 mal fields; Group III, 14 patients receiving carbamazepine monotherapy; Group IV, 20 normal individua
226 cated agents were lamotrigine, azithromycin, carbamazepine, moxifloxacin, cephalexin, diclofenac, and
227 e review reporting genetic associations with carbamazepine (n = 31), other aromatic antiepileptic dru
228 similar irrespective of the system, and with carbamazepine no significant degradation was obtained.
229 s further evident at a cellular level, where carbamazepine normalized the hyperexcitability of dorsal
230 is usually resistant to pharmacotherapy, but carbamazepine normalizes activation of Na(V)1.7-V400M mu
232 how that between 95% (4-iodophenol) and 67% (carbamazepine) of the total internal amount in 26 h post
233 technology was used to assess the effect of carbamazepine on firing of DRG neurons carrying S241T mu
235 xture exposure to propranolol, diazepam, and carbamazepine on the crustacean Daphnia magna at environ
237 We recruited 34 epilepsy patients taking carbamazepine or phenytoin in monotherapy whose physicia
238 g epilepsy patients from the enzyme-inducers carbamazepine or phenytoin to the noninducing drugs leve
240 nic use of many antiepileptic drugs, such as carbamazepine, oxcarbazepine, and topiramate, enhances h
241 tments of BD such as valproate, lamotrigine, carbamazepine, oxcarbazepine, antipsychotics, electrocon
246 ere significantly less in subjects receiving carbamazepine, phenytoin, and valproate than in those re
247 esults of the one-step CEDIA for three AEDs (carbamazepine, phenytoin, and valproic acid), in the pre
248 f bone mass in women, and both phenytoin and carbamazepine produce increases in serum lipids and C-re
249 sy patients, switch from either phenytoin or carbamazepine produced significant declines in total cho
250 sing measured photolysis rates for atenolol, carbamazepine, propranolol, and sulfamethoxazole in wetl
251 actory solid tumors and to determine whether carbamazepine reduces oxaliplatin-induced neurotoxicity.
252 this study, a mechanism is proposed by which carbamazepine resists biodegradation, and a previously u
254 1.7-V400M mutant channels from a family with carbamazepine-responsive inherited erythromelalgia.
256 .62, 95% credible interval [CrI] 0.38-1.03), carbamazepine (RR 0.68, 0.44-1.06), imipramine (RR 0.95,
259 n identity test for monoclonal antibodies to carbamazepine, sirolimus, tacrolimus, cyclosporine, cort
260 the cytotoxic T lymphocytes of patients with carbamazepine-SJS/TEN, with its expression showing drug/
262 peroning mechanism wherein glibenclamide and carbamazepine stabilize the heteromeric subunit interfac
263 xaliplatin); regimen B (to determine whether carbamazepine starting 24 hours before and ending 48 hou
264 ment with 300 microM lidocaine or 300 microM carbamazepine, suggesting that lacosamide, lidocaine, an
265 nd that the wastewater borne MPs diclofenac, carbamazepine, sulfamethoxazole, acesulfame, sucralose,
266 ponent (bisphenol A), three pharmaceuticals (carbamazepine, sulfamethoxazole, and meprobamate), and t
268 r the HLA-B*1502 allele before initiation of carbamazepine therapy in patients of Asian ancestry, but
271 all molecule screens, we observed binding of carbamazepine to the cysteine-rich domain (CRD) of the W
273 at the observed uptake in the fluoxetine and carbamazepine treatments was due to the parent compounds
274 representative OMPs (i.e., sulfamethoxazole, carbamazepine, tylosin, atrazine, naproxen, and ibuprofe
276 ) and toxic epidermal necrolysis (TEN) among carbamazepine users, especially in some racial/ethnic po
277 ineffective, while valproate, gabapentin and carbamazepine varied in their potencies, with only the l
279 on treatment with low doses of rapamycin and carbamazepine was able to attenuate cyst formation as ef
280 sformation of trimethoprim, propranolol, and carbamazepine was attributed to direct electron transfer
283 icking rescue by reversible sulfonylureas or carbamazepine was facilitated by the KATP channel opener
286 d-state-fermentation conditions, 10,11-epoxy carbamazepine was further metabolized via acridine and 1
291 and functional analysis to be responsive to carbamazepine, was assessed in a double-blind, placebo-c
293 hium, quetiapine, olanzapine, bupropion, and carbamazepine were associated with high morbidity indice
294 -dihydro-10,11,-dihydroxy-carbamazepine, and carbamazepine were the most persistent (t1/2 = 12 +/- 2.
295 ants such as sucralose, sulfamethoxazole and carbamazepine, which are typical wastewater markers in r
296 taking placebo to 274.1 minutes while taking carbamazepine, while patient 2 reported a reduction of t
297 dwater and revealed persistence for the drug carbamazepine, while the herbicide MCPA (2-methyl-4-chlo
298 ds ranged from 0.5 (fluoxetine) to 306 days (carbamazepine), with 20 substances responding significan
299 attenuation of all compounds studied except carbamazepine within an area similar to that typical of